Cheung LC, Cruickshank MN, Hughes AM, Singh S, Chua G-A, Ford J, Ferrari E, Oommen J, Malinge S, Lock RB, Kees UR, Kotecha RS. Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia. Haematologica 2019; 104(7):e300-e303; https://doi.org/10.3324/haematol.2018.192906.